Related Experiment Video
Updated: Jun 18, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Prevention of late postmyocardial infarction left ventricular remodeling: an update
Farouk Mookadam1, Sherif E Moustafa
1Department of Cardiovascular Diseases, Mayo College of Medicine, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. mookadam.farouk@mayo.edu
Insights
Cardiac remodeling is a key target for heart attack and heart failure patients. This review covers current and future therapies aimed at preventing and reversing adverse cardiac remodeling after myocardial infarction (MI).
Area of Science:
- Cardiology
- Heart Failure Research
- Myocardial Infarction Studies
Background:
- Cardiac remodeling is a critical mechanism driving heart failure progression after myocardial infarction (MI).
- Increased survival from acute MI necessitates strategies to manage long-term consequences like adverse ventricular remodeling.
- Left ventricular remodeling serves as a vital surrogate marker for clinical outcomes in heart failure patients.
Purpose of the Study:
- To review the impact of existing and emerging therapeutic strategies on left ventricular remodeling and dysfunction post-MI.
- To provide a comprehensive overview of interventions targeting cardiac remodeling.
- To highlight future directions in preventing and reversing adverse cardiac remodeling.
Main Methods:
- Literature review of current and experimental therapeutic strategies.
- Analysis of pharmacotherapy, percutaneous interventions, device-based therapies, and surgical procedures.
- Synthesis of research on novel approaches to cardiac remodeling.
Main Results:
- Established therapies including pharmacotherapy and interventions help manage remodeling.
- Experimental research is yielding novel approaches for remodeling prevention and reversal.
- Understanding remodeling mechanisms is crucial for improving patient outcomes after MI.
Conclusions:
- Effective management of cardiac remodeling is essential for improving prognosis in MI survivors.
- A combination of current and future therapies holds promise for preventing and reversing adverse cardiac remodeling.
- Continued research into novel therapeutic strategies is vital for advancing heart failure treatment.
Abstract:
Cardiac remodeling remains an important primary therapeutic target in patients with myocardial infarction (MI) and chronic heart failure. It also has utility as a reliable surrogate for clinical outcomes. The past three decades of research have demonstrated the importance of cardiac remodeling as a basic mechanism in the progression of heart failure. Novel therapeutic advances have allowed more patients to survive acute MI. Strategies to prevent or halt adverse left ventricular remodeling have included pharmacotherapy, percutaneous interventions, device-based therapies, and surgical procedures. More recently, experimental research has added opportunities for novel approaches to prevent and reverse cardiac remodeling. This review summarizes the effects of current and future therapeutic strategies on left ventricular remodeling and dysfunction after MI.
More Related Videos
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease IV: Preventive Measures
Aortic Regurgitation III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Myocarditis III: Medical Management